MARTINI, Miriam
 Distribuzione geografica
Continente #
NA - Nord America 4.056
EU - Europa 2.292
AS - Asia 2.132
SA - Sud America 250
AF - Africa 65
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.806
Nazione #
US - Stati Uniti d'America 3.981
CN - Cina 917
IT - Italia 742
SG - Singapore 731
DK - Danimarca 391
DE - Germania 201
BR - Brasile 197
IE - Irlanda 159
FR - Francia 127
SE - Svezia 107
AT - Austria 92
VN - Vietnam 92
FI - Finlandia 91
UA - Ucraina 79
HK - Hong Kong 72
GB - Regno Unito 69
IN - India 68
KR - Corea 64
PL - Polonia 53
JP - Giappone 45
BE - Belgio 43
CA - Canada 42
SN - Senegal 41
NL - Olanda 33
ID - Indonesia 27
ES - Italia 26
AR - Argentina 24
MX - Messico 23
IR - Iran 22
TR - Turchia 21
RU - Federazione Russa 20
CH - Svizzera 14
PT - Portogallo 14
PK - Pakistan 11
AU - Australia 9
BD - Bangladesh 9
EC - Ecuador 9
ZA - Sudafrica 9
IL - Israele 8
NO - Norvegia 7
IQ - Iraq 6
UZ - Uzbekistan 6
CL - Cile 5
GR - Grecia 5
SA - Arabia Saudita 5
VE - Venezuela 5
JO - Giordania 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CO - Colombia 3
MA - Marocco 3
MK - Macedonia 3
TW - Taiwan 3
A1 - Anonimo 2
BO - Bolivia 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GH - Ghana 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KZ - Kazakistan 2
LT - Lituania 2
LY - Libia 2
MY - Malesia 2
PS - Palestinian Territory 2
RO - Romania 2
TT - Trinidad e Tobago 2
AL - Albania 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BZ - Belize 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
RE - Reunion 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
Totale 8.806
Città #
Ann Arbor 926
Chandler 422
Singapore 377
Ashburn 282
Beijing 225
Santa Clara 192
Torino 169
Turin 166
Dublin 155
Hangzhou 128
Houston 119
Dearborn 105
Fairfield 101
Wilmington 92
Vienna 80
Dallas 66
Nyköping 62
Villeurbanne 57
Jacksonville 51
Princeton 49
Buffalo 48
Columbus 48
Hong Kong 48
Medford 46
Guangzhou 43
Munich 43
Warsaw 42
Woodbridge 41
Shanghai 39
Cambridge 38
Milan 38
Seattle 38
Los Angeles 36
Redwood City 34
Pisa 32
Boardman 31
Fremont 30
Boston 29
Dong Ket 29
Hefei 28
Brussels 24
Jakarta 24
Asti 23
Fortaleza 23
Seoul 23
The Dalles 22
Turku 22
Ho Chi Minh City 21
New York 21
Nanjing 20
Shenyang 20
Washington 19
Nuremberg 17
Tokyo 17
Paris 16
Hanoi 15
Berlin 13
Madrid 13
Chengdu 12
Tianjin 12
Amsterdam 11
Düsseldorf 11
Frankfurt am Main 11
London 11
New Delhi 11
Phoenix 11
Rome 11
San Diego 11
Bengaluru 10
Chennai 10
Helsinki 10
Jinan 10
Montréal 10
Redondo Beach 10
Toronto 10
Lappeenranta 9
Mexico City 9
São Paulo 9
Wuhan 9
Brooklyn 8
Chicago 8
Des Moines 8
Kocaeli 8
Verona 8
Central 7
Chongqing 7
Grafing 7
Hasselt 7
Kunming 7
Montreal 7
Naples 7
Xi'an 7
Xian 7
Belo Horizonte 6
Bergamo 6
Carrara 6
Falls Church 6
Mexico 6
Padova 6
Palaiseau 6
Totale 5.301
Nome #
Phosphoinositide 3-Kinase Gamma Inhibition Protects from Anthracycline Cardiotoxicity and Reduces Tumor Growth 803
Cytokinetic abscission: Phosphoinositides and ESCRTs direct the final cut 431
BRAF V600E is a determinant of sensitivity to proteasome inhibitors. 389
Measurement of PIP3 levels reveals an unexpected role for p110β in early adaptive responses to p110α-specific inhibitors in luminal breast cancer 373
PI3K/AKT signaling pathway and cancer: an updated review. 366
PI3K Class II α Controls Spatially Restricted Endosomal PtdIns3P and Rab11 Activation to Promote Primary Cilium Function. 325
Signaling pathways regulating redox balance in cancer metabolism 317
Mixed lineage kinase MLK4 is activated in colorectal cancers where it synergistically cooperates with activated RAS signaling in driving tumorigenesis 287
PI3K keeps the balance between metabolism and cancer. 274
Targeting PI3K in Cancer: Any Good News? 265
Effects of KRAS, BRAF, NRAS and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective population-based Consortium analysis 259
PI3K in cancer-stroma interactions: bad in seed and ugly in soil. 252
Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function 205
PI3K Signaling in Tissue Hyper-Proliferation: From Overgrowth Syndromes to Kidney Cysts 197
Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia 196
Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers 179
Knock-in of oncogenic mutations in human somatic cells as a tool to identify genoselective compounds 166
MLK4 gene, a new diagnostic and prognostic marker in cancers 163
A novel multiplex qrt-pcr assay to detect sars-cov-2 infection: High sensitivity and increased testing capacity 163
EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES 161
How PI3K-derived lipids control cell division 159
Class II PI3K Functions in Cell Biology and Disease 149
Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer 144
BRAF V600E confers resistance to cetuximab or panitumumab metastatic colorectal cancer 136
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 133
Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy 132
Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer 131
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia 128
Modeling tumor progression by the sequential introduction of genetic alterations into the genome of human normal cells 127
PI(3,4)P2 Signaling in Cancer and Metabolism 127
Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis 124
Phosphoinositide Conversion Inactivates R-RAS and Drives Metastases in Breast Cancer 123
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses 117
Rac signal adaptation controls neutrophil mobilization from the bone marrow 114
Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes 113
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer 109
PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies 105
PI(3,4)P2-mediated cytokinetic abscission prevents early senescence and cataract formation 104
Targeted therapies: how personal should we go? 103
Exploiting pancreatic cancer metabolism: challenges and opportunities 98
Targeting PI3K signaling in cancer: Challenges and advances 94
The impact of COVID-19 on pancreatic cancer research and the path forward 93
Defective lipid signalling caused by mutations in PIK3C2B underlies focal epilepsy 87
The turtle and the rabbit story in a modern (PI3)key 87
Phosphoinositides in cell proliferation and metabolism 87
Metabolic plasticity in pancreatic cancer: The mitochondrial connection 85
The role of metabolic adaptation to nutrient stress in pancreatic cancer 85
Cholesterol Activates Cyclic AMP Signaling in Metaplastic Acinar Cells 82
Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer 50
Science around the world 5
Totale 9.002
Categoria #
all - tutte 25.416
article - articoli 0
book - libri 0
conference - conferenze 1.421
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.837


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021448 0 0 0 0 0 31 60 30 76 49 41 161
2021/20221.419 173 168 144 187 75 71 80 67 52 56 195 151
2022/20231.186 126 110 49 129 82 262 78 76 142 17 48 67
2023/2024703 75 79 66 48 59 67 59 47 14 69 49 71
2024/20251.679 47 92 72 157 320 130 63 115 218 102 169 194
2025/20261.145 333 103 174 256 262 17 0 0 0 0 0 0
Totale 9.002